U
PBE icon

UBS’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

UBS’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$16.1M Buy
348,011
+1,866
+0.5% +$84.1K 0.01% 1099
2014
Q2 		$15.1M Sell
346,145
-74,672
-18% -$3.03M 0.01% 1061
2014
Q1 		$17.5M Buy
420,817
+79,611
+23% +$3.41M 0.02% 875
2013
Q4 		$12.6M Buy
341,206
+148,305
+77% +$5.32M 0.01% 1093
2013
Q3 		$6.76M Buy
192,901
+2,755
+1% +$91.2K 0.01% 1448
2013
Q2 		$5.49M Buy
+190,146
New +$5.41M 0.01% 1535

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TAM
Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SAM
SignalPoint Asset Management Springfield, Missouri $411M AUM 23.81% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return

UBS's PBE Position: Q3 2014 in Review

UBS increased its Invesco Biotechnology & Genome ETF (PBE) stake by 0.54% in Q3 2014, buying an estimated $84.1K and bringing the position to 348,011 shares worth $16.1M. The position accounts for 0.01% of the portfolio, ranked #1099.

UBS first reported a position in PBE in Q2 2013 and has held it in 6 quarters since. The position peaked at $17.5M in Q1 2014. 70 funds tracked by Wall St. Rank hold PBE as of Q3 2014.

  • UBS held 348,011 shares of Invesco Biotechnology & Genome ETF worth $16.1M as of Q3 2014.
  • UBS bought 1,866 Invesco Biotechnology & Genome ETF shares in Q3 2014, an estimated $84.1K.
  • Invesco Biotechnology & Genome ETF made up 0.01% of UBS's portfolio in Q3 2014, its #1099 holding.
  • UBS first reported a position in Invesco Biotechnology & Genome ETF in Q2 2013 and has held it in 6 quarters since.
  • UBS's Invesco Biotechnology & Genome ETF position peaked at $17.5M in Q1 2014.
  • 70 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.